Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.
Share this post
Latest News posts
Assistance for Patients Who Cannot Afford Antifungal Drugs (US only)
February 15, 2019
How do I know that this research paper is any good?
February 15, 2019
Treat the Causes of Chronic Disease, Not the Symptoms
February 14, 2019
How do I describe symptoms to my doctor?
February 14, 2019
New Diagnostics Tool
February 7, 2019
Take a look around a mycology laboratory!
February 7, 2019
WHO WANTS TO LIVE FOREVER? by Elizabeth Hutton
January 30, 2019
‘I’M STILL STANDING – (ME ‘N ELTON!) by Elizabeth Hutton
January 30, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video